Kraig Biocraft Laboratories Inc (KBLB): No reason to do a RS when a buyout is in...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Re: rayovac812 post# 233592

Monday, 01/03/2022 1:50:54 PM

Monday, January 03, 2022 1:50:54 PM

No reason to do a RS when a buyout is in the wings.....maybe from the independent source doing the testing????

Just a thought?

M-37

Keep Last Read

Replies (1) Next 10 Prev Next

Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/16/2024 09:00:29 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:30:52 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/10/2024 08:30:30 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/04/2024 04:15:03 AM
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM

InvestorsHub NewsWire

Only $200 per official company press release!